View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, Oct. 31 (HealthDay News) -- Women testing negative for their family-specific BRCA1 or BRCA2 mutation (noncarriers) do not have an increased risk of breast cancer, according to a study published online Oct. 31 in the Journal of Clinical Oncology.
Allison W. Kurian, M.D., from the Stanford University School of Medicine in California, and colleagues estimated breast cancer risks for women who were not carriers of the BRCA1 or BRCA2 mutation. Women with breast cancer from 3,047 families in the Breast Cancer Family Registry and their female first degree relatives (FDRs) were tested for BRCA1 and BRCA2 mutations.
The investigators identified 160 families with BRCA1 and 132 with BRCA2 mutations. Noncarriers of identified mutations had no evidence of increased breast cancer risk compared with FDRs from families without BRCA1 or BRCA2 mutations (relative risk, 0.39; 95 percent confidence interval, 0.04 to 3.81). There was a strong residual breast cancer association within families, with 3.4 percent of women without BRCA1 or BRCA2 mutations accounting for approximately one third of breast cancer cases.
"We found no evidence for an increase in breast cancer risk for noncarriers of a family-specific BRCA1 or BRCA2 mutation in this study of 3,047 population-based families recruited from three countries," the authors write.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top